Package 72241-020-05

{"route": ["ORAL"], "spl_id": "fe5a706a-47cf-47d4-a6ed-db4e7f08a169", "openfda": {"upc": ["0372241020117", "0378241021116", "0372241021114"], "unii": ["ZG7E5POY8O"], "rxcui": ["993687", "993691"], "spl_set_id": ["0961f83e-25e9-4ffc-8669-44e4e9169978"], "manufacturer_name": ["Modavar Pharmaceuticals LLC"], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "100 TABLET, FILM COATED in 1 BOTTLE (72241-020-05)", "package_ndc": "72241-020-05", "marketing_start_date": "20230112"}, {"sample": false, "description": "1000 TABLET, FILM COATED in 1 BOTTLE (72241-020-11)", "package_ndc": "72241-020-11", "marketing_start_date": "20230112"}, {"sample": false, "description": "10 BLISTER PACK in 1 CARTON (72241-020-17)  / 10 TABLET, FILM COATED in 1 BLISTER PACK", "package_ndc": "72241-020-17", "marketing_start_date": "20230112"}], "brand_name": "Bupropion Hydrochloride", "product_id": "72241-020_fe5a706a-47cf-47d4-a6ed-db4e7f08a169", "dosage_form": "TABLET, FILM COATED", "pharm_class": ["Aminoketone [EPC]", "Dopamine Uptake Inhibitors [MoA]", "Increased Dopamine Activity [PE]", "Increased Norepinephrine Activity [PE]", "Norepinephrine Uptake Inhibitors [MoA]"], "product_ndc": "72241-020", "generic_name": "Bupropion Hydrochloride", "labeler_name": "Modavar Pharmaceuticals LLC", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "Bupropion Hydrochloride", "active_ingredients": [{"name": "BUPROPION HYDROCHLORIDE", "strength": "75 mg/1"}], "application_number": "ANDA208606", "marketing_category": "ANDA", "marketing_start_date": "20200116", "listing_expiration_date": "20261231"}